227 related articles for article (PubMed ID: 12746697)
21. Successive motor nerve blocks to identify the muscles causing a spasticity pattern: example of the arm flexion pattern.
Genet F; Schnitzler A; Droz-Bartholet F; Salga M; Tatu L; Debaud C; Denormandie P; Parratte B
J Anat; 2017 Jan; 230(1):106-116. PubMed ID: 27595994
[TBL] [Abstract][Full Text] [Related]
22. [Peripheral neurolytic blocks and spasticity].
Viel E; Pellas F; Ripart J; Pélissier J; Eledjam JJ
Ann Fr Anesth Reanim; 2005 Jun; 24(6):667-72. PubMed ID: 15950114
[TBL] [Abstract][Full Text] [Related]
23. Recovery of motor disability and spasticity in post-stroke after repetitive transcranial magnetic stimulation (rTMS).
Málly J; Dinya E
Brain Res Bull; 2008 Jul; 76(4):388-95. PubMed ID: 18502315
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous phenol blocks to motor points of spastic forearm muscles in head-injured adults.
Garland DE; Lilling M; Keenan MA
Arch Phys Med Rehabil; 1984 May; 65(5):243-5. PubMed ID: 6712448
[TBL] [Abstract][Full Text] [Related]
25. Interrater reliability of Modified Ashworth Scale and Modified Tardieu Scale in children with spastic cerebral palsy.
Yam WK; Leung MS
J Child Neurol; 2006 Dec; 21(12):1031-5. PubMed ID: 17156693
[TBL] [Abstract][Full Text] [Related]
26. Evidence of increased motoneuron excitability in stroke patients without clinical spasticity.
Udby Blicher J; Nielsen JF
Neurorehabil Neural Repair; 2009 Jan; 23(1):14-6. PubMed ID: 18794219
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of spastic muscle in stroke survivors using magnetic resonance imaging and resistance to passive motion.
Ploutz-Snyder LL; Clark BC; Logan L; Turk M
Arch Phys Med Rehabil; 2006 Dec; 87(12):1636-42. PubMed ID: 17141645
[TBL] [Abstract][Full Text] [Related]
28. Relationships between spasticity, strength, gait, and the GMFM-66 in persons with spastic diplegia cerebral palsy.
Ross SA; Engsberg JR
Arch Phys Med Rehabil; 2007 Sep; 88(9):1114-20. PubMed ID: 17826455
[TBL] [Abstract][Full Text] [Related]
29. An investigation into the agreement between clinical, biomechanical and neurophysiological measures of spasticity.
Malhotra S; Cousins E; Ward A; Day C; Jones P; Roffe C; Pandyan A
Clin Rehabil; 2008 Dec; 22(12):1105-15. PubMed ID: 19052249
[TBL] [Abstract][Full Text] [Related]
30. Relationships among measures of knee musculoskeletal impairments, gross motor function, and walking efficiency in children with cerebral palsy.
Goh HT; Thompson M; Huang WB; Schafer S
Pediatr Phys Ther; 2006; 18(4):253-61. PubMed ID: 17108798
[TBL] [Abstract][Full Text] [Related]
31. [Surgical management of spasticity of the intrinsic muscles of the long fingers in adults after cerebral palsy, 68 operated hands].
Saintyves G; Genet F; Allieu Y; Judet T; Denormandie P
Chir Main; 2011 Feb; 30(1):46-51. PubMed ID: 21367637
[TBL] [Abstract][Full Text] [Related]
32. Traditional pharmacological treatments for spasticity. Part I: Local treatments.
Gracies JM; Elovic E; McGuire J; Simpson DM
Muscle Nerve Suppl; 1997; 6():S61-91. PubMed ID: 9826983
[TBL] [Abstract][Full Text] [Related]
33. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
34. The effects of clonidine on postoperative analgesia after peripheral nerve blockade in children.
Cucchiaro G; Ganesh A
Anesth Analg; 2007 Mar; 104(3):532-7. PubMed ID: 17312203
[TBL] [Abstract][Full Text] [Related]
35. [Rhizotomy for children with severe spastic cerebral palsy].
Illum NO; Torp-Pedersen L; Midholm S; Selmar PE; Simesen K
Ugeskr Laeger; 2006 Feb; 168(8):785-9. PubMed ID: 16499843
[TBL] [Abstract][Full Text] [Related]
36. Knee resistance during passive stretch in patients with hypertonia.
Lebiedowska MK; Fisk JR
J Neurosci Methods; 2009 May; 179(2):323-30. PubMed ID: 19428544
[TBL] [Abstract][Full Text] [Related]
37. Walking speed modifies spasticity effects in gastrocnemius and soleus in cerebral palsy gait.
van der Krogt MM; Doorenbosch CA; Becher JG; Harlaar J
Clin Biomech (Bristol, Avon); 2009 Jun; 24(5):422-8. PubMed ID: 19349103
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
39. Gait control in spinal palsy.
Dan B; Bouillot E; Mewasingh LD; Devalck C; Bengoetxea A; Christophe C; Chéron G
Brain Dev; 2004 Oct; 26(7):463-8. PubMed ID: 15351083
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
